Home > Research > Publications & Outputs > Case management for patients with chronic systo...
View graph of relations

Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial

Research output: Contribution to journalJournal article

Published

Standard

Case management for patients with chronic systolic heart failure in primary care : the HICMan exploratory randomised controlled trial. / Peters-Klimm, Frank; Campbell, Stephen; Hermann, Katja; Kunz, Cornelia U.; Müller-Tasch, Thomas; Szecsenyi, Joachim; Competence Network Heart Failure.

In: Trials, Vol. 11, 56, 17.05.2010.

Research output: Contribution to journalJournal article

Harvard

Peters-Klimm, F, Campbell, S, Hermann, K, Kunz, CU, Müller-Tasch, T, Szecsenyi, J & Competence Network Heart Failure 2010, 'Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial', Trials, vol. 11, 56. https://doi.org/10.1186/1745-6215-11-56

APA

Peters-Klimm, F., Campbell, S., Hermann, K., Kunz, C. U., Müller-Tasch, T., Szecsenyi, J., & Competence Network Heart Failure (2010). Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial. Trials, 11, [56]. https://doi.org/10.1186/1745-6215-11-56

Vancouver

Author

Peters-Klimm, Frank ; Campbell, Stephen ; Hermann, Katja ; Kunz, Cornelia U. ; Müller-Tasch, Thomas ; Szecsenyi, Joachim ; Competence Network Heart Failure. / Case management for patients with chronic systolic heart failure in primary care : the HICMan exploratory randomised controlled trial. In: Trials. 2010 ; Vol. 11.

Bibtex

@article{92c7b2dff6814a4d8dd8a6597af73afb,
title = "Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial",
abstract = "BACKGROUND: Chronic (systolic) heart failure (CHF) represents a clinical syndrome with high individual and societal burden of disease. Multifaceted interventions like case management are seen as promising ways of improving patient outcomes, but lack a robust evidence base, especially for primary care. The aim of the study was to explore the effectiveness of a new model of CHF case management conducted by doctors' assistants (DAs, equivalent to a nursing role) and supported by general practitioners (GPs).METHODS: This patient-randomised controlled trial (phase II) included 31 DAs and employing GPs from 29 small office-based practices in Germany. Patients with CHF received either case management (n = 99) consisting of telephone monitoring and home visits or usual care (n = 100) for 12 months. We obtained clinical data, health care utilisation data, and patient-reported data on generic and disease-specific quality of life (QoL, SF-36 and KCCQ), CHF self-care (EHFScBS) and on quality of care (PACIC-5A). To compare between groups at follow-up, we performed analyses of covariance and logistic regression models.RESULTS: Baseline measurement showed high guideline adherence to evidence-based pharmacotherapy and good patient self-care: Patients received angiotensin converting enzyme inhibitors (or angiotensin-2 receptor antagonists) in 93.8{\%} and 95{\%}, and betablockers in 72.2{\%} and 84{\%}, and received both in combination in 68{\%} and 80{\%} of cases respectively. EHFScBS scores (SD) were 25.4 (8.4) and 25.0 (7.1). KCCQ overall summary scores (SD) were 65.4 (22.6) and 64.7 (22.7). We found low hospital admission and mortality rates. EHFScBS scores (-3.6 [-5.7;-1.6]) and PACIC and 5A scores (both 0.5, [0.3;0.7/0.8]) improved in favour of CM but QoL scores showed no significant group differences (Physical/Mental SF-36 summary scores/KCCQ-os [95{\%}CI]: -0.3 [-3.0;2.5]/-0.1 [-3.4;3.1]/1.7 [-3.0;6.4]).CONCLUSIONS: In this sample, with little room for improvement regarding evidence-based pharmacotherapy and CHF self-care, case management showed no improved health outcomes or health care utilisation. However, case management significantly improved performance and key intermediate outcomes. Our study provides evidence for the feasibility of the case management model.TRIAL REGISTRATION NUMBER: ISRCTN30822978.",
keywords = "Aged, Aged, 80 and over, Cardiovascular Agents, Case Management, Chronic Disease, Evidence-Based Medicine, Feasibility Studies, Female, Germany, Guideline Adherence, Heart Failure, Systolic, Hospitalization, House Calls, Humans, Logistic Models, Male, Middle Aged, Outcome and Process Assessment (Health Care), Physician Assistants, Physicians, Family, Practice Guidelines as Topic, Primary Health Care, Quality of Health Care, Quality of Life, Self Care, Telephone, Time Factors, Treatment Outcome",
author = "Frank Peters-Klimm and Stephen Campbell and Katja Hermann and Kunz, {Cornelia U.} and Thomas M{\"u}ller-Tasch and Joachim Szecsenyi and {Competence Network Heart Failure}",
year = "2010",
month = "5",
day = "17",
doi = "10.1186/1745-6215-11-56",
language = "English",
volume = "11",
journal = "Trials",
issn = "1745-6215",
publisher = "BIOMED CENTRAL LTD",

}

RIS

TY - JOUR

T1 - Case management for patients with chronic systolic heart failure in primary care

T2 - the HICMan exploratory randomised controlled trial

AU - Peters-Klimm, Frank

AU - Campbell, Stephen

AU - Hermann, Katja

AU - Kunz, Cornelia U.

AU - Müller-Tasch, Thomas

AU - Szecsenyi, Joachim

AU - Competence Network Heart Failure

PY - 2010/5/17

Y1 - 2010/5/17

N2 - BACKGROUND: Chronic (systolic) heart failure (CHF) represents a clinical syndrome with high individual and societal burden of disease. Multifaceted interventions like case management are seen as promising ways of improving patient outcomes, but lack a robust evidence base, especially for primary care. The aim of the study was to explore the effectiveness of a new model of CHF case management conducted by doctors' assistants (DAs, equivalent to a nursing role) and supported by general practitioners (GPs).METHODS: This patient-randomised controlled trial (phase II) included 31 DAs and employing GPs from 29 small office-based practices in Germany. Patients with CHF received either case management (n = 99) consisting of telephone monitoring and home visits or usual care (n = 100) for 12 months. We obtained clinical data, health care utilisation data, and patient-reported data on generic and disease-specific quality of life (QoL, SF-36 and KCCQ), CHF self-care (EHFScBS) and on quality of care (PACIC-5A). To compare between groups at follow-up, we performed analyses of covariance and logistic regression models.RESULTS: Baseline measurement showed high guideline adherence to evidence-based pharmacotherapy and good patient self-care: Patients received angiotensin converting enzyme inhibitors (or angiotensin-2 receptor antagonists) in 93.8% and 95%, and betablockers in 72.2% and 84%, and received both in combination in 68% and 80% of cases respectively. EHFScBS scores (SD) were 25.4 (8.4) and 25.0 (7.1). KCCQ overall summary scores (SD) were 65.4 (22.6) and 64.7 (22.7). We found low hospital admission and mortality rates. EHFScBS scores (-3.6 [-5.7;-1.6]) and PACIC and 5A scores (both 0.5, [0.3;0.7/0.8]) improved in favour of CM but QoL scores showed no significant group differences (Physical/Mental SF-36 summary scores/KCCQ-os [95%CI]: -0.3 [-3.0;2.5]/-0.1 [-3.4;3.1]/1.7 [-3.0;6.4]).CONCLUSIONS: In this sample, with little room for improvement regarding evidence-based pharmacotherapy and CHF self-care, case management showed no improved health outcomes or health care utilisation. However, case management significantly improved performance and key intermediate outcomes. Our study provides evidence for the feasibility of the case management model.TRIAL REGISTRATION NUMBER: ISRCTN30822978.

AB - BACKGROUND: Chronic (systolic) heart failure (CHF) represents a clinical syndrome with high individual and societal burden of disease. Multifaceted interventions like case management are seen as promising ways of improving patient outcomes, but lack a robust evidence base, especially for primary care. The aim of the study was to explore the effectiveness of a new model of CHF case management conducted by doctors' assistants (DAs, equivalent to a nursing role) and supported by general practitioners (GPs).METHODS: This patient-randomised controlled trial (phase II) included 31 DAs and employing GPs from 29 small office-based practices in Germany. Patients with CHF received either case management (n = 99) consisting of telephone monitoring and home visits or usual care (n = 100) for 12 months. We obtained clinical data, health care utilisation data, and patient-reported data on generic and disease-specific quality of life (QoL, SF-36 and KCCQ), CHF self-care (EHFScBS) and on quality of care (PACIC-5A). To compare between groups at follow-up, we performed analyses of covariance and logistic regression models.RESULTS: Baseline measurement showed high guideline adherence to evidence-based pharmacotherapy and good patient self-care: Patients received angiotensin converting enzyme inhibitors (or angiotensin-2 receptor antagonists) in 93.8% and 95%, and betablockers in 72.2% and 84%, and received both in combination in 68% and 80% of cases respectively. EHFScBS scores (SD) were 25.4 (8.4) and 25.0 (7.1). KCCQ overall summary scores (SD) were 65.4 (22.6) and 64.7 (22.7). We found low hospital admission and mortality rates. EHFScBS scores (-3.6 [-5.7;-1.6]) and PACIC and 5A scores (both 0.5, [0.3;0.7/0.8]) improved in favour of CM but QoL scores showed no significant group differences (Physical/Mental SF-36 summary scores/KCCQ-os [95%CI]: -0.3 [-3.0;2.5]/-0.1 [-3.4;3.1]/1.7 [-3.0;6.4]).CONCLUSIONS: In this sample, with little room for improvement regarding evidence-based pharmacotherapy and CHF self-care, case management showed no improved health outcomes or health care utilisation. However, case management significantly improved performance and key intermediate outcomes. Our study provides evidence for the feasibility of the case management model.TRIAL REGISTRATION NUMBER: ISRCTN30822978.

KW - Aged

KW - Aged, 80 and over

KW - Cardiovascular Agents

KW - Case Management

KW - Chronic Disease

KW - Evidence-Based Medicine

KW - Feasibility Studies

KW - Female

KW - Germany

KW - Guideline Adherence

KW - Heart Failure, Systolic

KW - Hospitalization

KW - House Calls

KW - Humans

KW - Logistic Models

KW - Male

KW - Middle Aged

KW - Outcome and Process Assessment (Health Care)

KW - Physician Assistants

KW - Physicians, Family

KW - Practice Guidelines as Topic

KW - Primary Health Care

KW - Quality of Health Care

KW - Quality of Life

KW - Self Care

KW - Telephone

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1186/1745-6215-11-56

DO - 10.1186/1745-6215-11-56

M3 - Journal article

C2 - 20478035

VL - 11

JO - Trials

JF - Trials

SN - 1745-6215

M1 - 56

ER -